Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

390 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.

NCT06043193

Conditions: Metastatic Neuroendocrine Tumour, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: CHU de Saint-Etienne, Hôpital Nord Saint-Priest-en-Jarez, Saint-Etienne, France

CH Métropole Savoie Chambéry, France

Centre de Lutte Contre le Cancer Jean Perrin Clermont-Ferrand, France

Hospices Civils de Lyon, Hopital Lyon Sud Lyon, France

View Trial Details

Recruiting

Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors

NCT05870423

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Erasmus MC Rotterdam, South Holland, Netherlands

View Trial Details

Recruiting

61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)

NCT06455358

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University Hospital Basel, Department of Radiology and Nuclear Medicine Basel, Canton of Basel-City, Switzerland

View Trial Details

Recruiting

Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.

NCT04735198

Conditions: Biliary Stones, Biliary Tract Diseases, Cholecystolithiasis, +10 more
Locations: Hospital Universitari Trias i Pujol Badalona, Barcelona, Spain

IDIBELL, Hospital Universitari de Bellvitge. Barcelona, Spain

Hospital del Mar Barcelona, Spain

Hospital Universitari Vall d'Hebron Barcelona, Spain

View Trial Details

Recruiting

18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

NCT06937112

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +21 more
Locations: Nanjing First Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

NCT04464122

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations: Andrea M Isidori Rome, Italy

View Trial Details

Recruiting

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

NCT06056362

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis

NCT06881511

Conditions: Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +20 more
Locations: The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

NCT05804331

Conditions: Cancer of Stomach, Digestive System Diseases, Digestive System Neoplasms, +20 more
Locations: Westmead Hospital Sydney, New South Wales, Australia

View Trial Details

Recruiting

Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)

NCT05165407

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Bejing cancer hospital Beijing, Beijing Municipality, China

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions